Rigel Pharmaceuticals reported $172K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acura Pharmaceuticals ACUR:US 651K 430K
Agenus AGEN:US $ 2.67M 0.1M
Amgen AMGN:US $ 31247M 849M
Anika Therapeutics ANIK:US $ 0.14M 0M
Applied Genetic Technologies AGTC:US $ 0.05M 0.01M
Arrowhead Research ARWR:US $ 198K 1000
Astrazeneca AZN:US $ 387M 0M
AstraZeneca AZN:LN 387M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Immunogen IMGN:US $ 2.2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Macrogenics MGNX:US $ 0.61M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Veracyte VCYT:US $ 0.07M 0M